JCJing-Yuan Cao

Jing-Yuan Cao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jing-Yuan Cao has a total of 211 co-authors. Here are the top co-authors by number of shared publications:

  • Guoyu Wang

    Department of Pan-Vascular Management Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University

    3 shared publications
  • Hong Liu

    Nephrology Department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People’s Republic of China

    3 shared publications
  • Hong Xu

    Department of Pan-Vascular Management Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University

    3 shared publications
  • Jing Zheng

    Department of Pan-Vascular Management Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University

    3 shared publications
  • Peng Gao

    Department of Pan-Vascular Management Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University

    3 shared publications
  • Qingqing Zhang

    Department of Pan-Vascular Management Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University

    3 shared publications

Latest Publications

  • Open Access

    Skeletal muscle–heart crosstalk in chronic kidney disease: hierarchical signaling networks underlying myocardial metabolic reprogramming and fibrotic remodeling

    by Haijing Lu, Boyin Liu, Jiazhou Ji, Lin Shuai, Jingyuan Cao

    Cardiovascular disease is a major complication of chronic kidney disease (CKD) and often develops alongside skeletal muscle wasting and sarcopenia. These abnormalities are usually studied as separate consequences of CKD, but they may also be linked through shared systemic stressors and inter-organ communication. CKD exposes both skeletal muscle and the myocardium to a persistent uremic milieu characterized by toxin retention, chronic inflammation, oxidative stress, hypoxia, and metabolic disturbance. In this setting, skeletal muscle–heart crosstalk may shift from an adaptive homeostatic program to a maladaptive network that contributes to myocardial metabolic dysfunction and fibrotic remodeling. Under physiological conditions, and especially during exercise, skeletal muscle releases myokines and extracellular vesicles carrying miRNAs, proteins, and other regulatory molecules that support myocardial substrate utilization, mitochondrial function, and repair responses. In CKD, however, altered myokine profiles and dysregulated extracellular vesicle cargoes may act on cardiomyocytes, cardiac fibroblasts, and endothelial cells, promoting impaired metabolic flexibility, extracellular matrix deposition, and progressive cardiac remodeling. The heart may also feed back on skeletal muscle through cardiac-derived endocrine signals and neurohumoral pathways, further reinforcing muscle wasting and systemic dysfunction. In this review, we summarize current evidence on skeletal muscle–heart communication under physiological, exercise-related, and CKD-associated conditions, with emphasis on myokines, extracellular vesicles, and miRNA-mediated signaling. Better definition of this axis may help identify biomarkers and therapeutic targets for CKD-associated sarcopenia and cardiovascular disease.

  • Open Access

    Precision Nanomedicine for Renal Tubular Injury: From Passive Accumulation to Subcellular Targeting

    by Yaotong Shi, Yuan Lu, Yan Zhou, Ruoxin Chen, Zuolin Li, Hong Liu, Jingyuan Cao

    Renal tubular epithelial cell injury is a central pathogenic feature of kidney diseases, yet precise therapeutic interventions remain elusive. Conventional nanomedicines relying on passive accumulation lack the specificity required to treat complex tubular pathologies. This review elucidates the evolution of renal nanotherapeutics from non-specific organ accumulation to active, biologically informed targeting. We examine strategies utilizing specific surface receptors and injury-associated microenvironmental signals to engineer ligand-directed and stimuli-responsive nanocarriers. Furthermore, we highlight biomimetic platforms, such as engineered extracellular vesicles. Crucially, to achieve the ultimate goal of precision intervention, we emphasize the necessity of subcellular targeting. With a primary focus on mitochondria, we delineate hierarchical delivery strategies designed to restore cellular bioenergetics and metabolic homeostasis. Finally, we provide a forward-looking perspective on overcoming translational barriers by integrating DNA barcoding and artificial intelligence to accelerate the discovery of clinically translatable, precision nanomedicines.


  • Open Access

    Associations of triglyceride-glucose-related indices and cardiovascular health with retinal arteriosclerosis: a cross-sectional study

    by Qingqing Zhang, Guoyu Wang, Hong Xu, Zixiang Li, Peng Gao, Jing Zheng, Suyun Jiang, Si Sun, Yucheng Wu, Jingyuan Cao, et al.

    Objective: Retinal arteriosclerosis (RA) is a visible marker of early microvascular injury largely driven by cardiovascular risk factors. Insulin resistance, represented by the triglyceride-glucose (TyG) related indices, may serve as a key mediator linking cardiovascular health (CVH) to RA. Methods: In this cross-sectional study of 755 healthcare staff aged ≥35 years, RA was defined as Keith-Wagener-Barker grade ≥1 on fundus photography, representing early subclinical retinal arteriolar changes. CVH was assessed using Life’s Essential 8 (LE8). TyG-related indices, including TyG, TyG combined with body mass index (TyG-BMI), TyG combined with body roundness index (TyG-BRI), TyG combined with waist circumference (TyG-WC), and TyG combined with the waist-to-height ratio (TyG-WHtR), were calculated. Logistic regression and mediation analyses were performed to evaluate the associations of TyG-related indices with RA, and their mediating role in the LE8–RA relationship. Results: RA was present in 159 participants (21.1%). Higher TyG-related indices were significantly associated with an increased odds of RA. In fully adjusted models, per SD increase in TyG was associated with a 40% higher odds of RA (OR = 1.40; 95% CI: 1.15–1.70; p = 0.001). Similar positive associations were observed for all obesity-related TyG indices. Higher LE8 scores were inversely associated with RA. Each 10-point increase in LE8 was associated with a 26% lower odds of RA (95% CI: 0.67–0.94; p < 0.001). RCS analyses indicated linear associations of TyG-related indices and LE8 with the risk of RA (all P -nonlinear > 0.05). Mediation analyses suggested that TyG-related indices statistically accounted for a substantial proportion of the inverse association between LE8 and RA, with mediated proportions ranging from 32.8 to 67.3%, consistent with a pattern of statistical full mediation. Conclusion: Higher TyG-related indices were associated with an increased risk of RA, whereas better CVH was associated with a lower risk. These findings underscore the importance of CVH in early retinal microvascular injury and support the potential role of TyG-related indices as simple risk markers.

  • Open Access

    The Interaction Between Triglyceride–Glucose Index and Visceral Adiposity in Arterial Stiffness

    by Guoyu Wang, Chuanmeng Zhang, Suyun Jiang, Qingqing Zhang, Peng Gao, Hong Xu, Jing Zheng, Si Sun, Jingyuan Cao, Li Zhu

    Background: Arterial stiffness is a critical determinant of cardiovascular risk and is influenced by various metabolic factors. The triglyceride-glucose (TyG) index, an emerging marker of insulin resistance, and visceral adiposity are both associated with arterial stiffness. However, the interaction between TyG index and visceral adiposity in relation to arterial stiffness has not been thoroughly explored. Methods: A total of 761 participants underwent health examinations, including measurements of fasting blood glucose, lipid profiles, visceral fat area (VFA), and arterial stiffness assessed by brachial-ankle pulse wave velocity (baPWV). Participants were stratified by TyG index and VFA. Logistics regression and interaction analyses were conducted to assess the combined effect of TyG and VFA on arterial stiffness. Results: Both the high TyG index and high VFA were independently associated with arterial stiffness(OR, 3.786, 95% CI 2.383, 6.014, p p <0.001, respectively). A significant interaction between TyG index and VFA on arterial stiffness was found (p for interaction <0.001), with a relative excess risk due to interaction (RERI) of -10.410 (95% CI -11.746, -9.074), an attributable proportion due to interaction (AP) of -1.474 (95% CI -1.644,-1.284), and an synergy index (SI) of 0.118 (95% CI 0.105, 0.131). Conclusions: The TyG index interacts with VFA on arterial stiffness. This interaction highlights the importance of considering both markers in risk assessment of arterial stiffness and prevention strategies aimed at improving vascular health.


  • White Matter Microstructural Alterations Are Linked to Cognitive Impairment in Patients with Fabry Disease: an Automated Fiber Quantification Study

    by Zhongru Sun, Yan Chen, Tianchi Liu, Zhaoting Li, Ning Wang, Ji Zhang, Jingyuan Cao, Jianguo Xia, Weizhong Tian

    Fabry disease (FD), an X‑linked lysosomal disorder caused by deficient α‑galactosidase A (α-Gal A), leads to glycosphingolipid accumulation and multi-organ damage. The specific characteristics and clinical relevance of white matter microstructural damage in FD remain insufficiently explored. This study therefore aimed to explore these specific changes using automated fiber quantification (AFQ), as well as to analyze their correlations with neuropsychological scales and clinical indicators. 19 FD patients and 22 healthy controls (HC) underwent neuropsychological assessments and diffusion tensor imaging (DTI). The AFQ technique was used to extract fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) values at 100 equidistant nodes along 18 major white matter tracts. Partial correlation analysis explored relationships between DTI indicators and neuropsychological as well as clinical indicators. ROC analysis was performed to evaluate the diagnostic efficacy of the FA and MD values in differentiating FD patients from HC. FD patients showed decreased FA values and increased MD, AD, and RD values in several fiber tracts, particularly in the corticospinal tract (CST) and the cingulum cingulate (CC). Diffusion metrics in the left CC (CC_L) showed significant correlations with neuropsychological scores: the FA values were positively correlated with the MMSE score, while the MD and RD values were negatively correlated with the MMSE score. Additionally, the MD and RD values were positively correlated with the HAMD and HAMA scores, respectively. The AD values of the left CST (CST_L), as well as the MD and AD values of the left arcuate fasciculus (AF_L), were negatively correlated with α‑galactosidase A (α-Gal A) activity in FD patients. Furthermore, ROC analysis demonstrated that the MD values of the right CST (CST_R) achieved superior diagnostic performance (AUC = 0.933). FD patients demonstrated segment-specific white matter damage. The abnormalities in these specific fiber segments were associated with symptoms such as cognitive impairment and depression, especially in the CC and CST. These findings may provide novel insights into the clinical symptoms associated with FD and offer new neuroimaging support for disease monitoring in this condition.

  • Open Access

    Association between Chinese visceral adiposity index and arterial stiffness among hospital workers in a Chinese tertiary hospital

    by Guoyu Wang, Peng Gao, Qingqing Zhang, Hong Xu, Jing Zheng, Suyun Jiang, Si Sun, Jingyuan Cao, Li Zhu

    Chinese visceral adiposity index (CVAI) has emerged as a reliable marker of visceral adiposity dysfunction. However, its relationship with arterial stiffness has yet to be comprehensively evaluated. This study investigated the association between CVAI and arterial stiffness in a cohort of hospital workers from a tertiary hospital. A cohort of hospital workers aged more than 35 years old, anticipating in physical examinations from September to October 2024, were enrolled in this study. Arterial stiffness was measured by brachial-ankle pulse wave velocity (baPWV). Visceral fat area (VFA) and subcutaneous fat area (SFA) were measured using the umbilical cord level double bioelectrical impedance analyzer. Correlation analysis, univariate and multivariate regression analysis, as well as receiver operating characteristic (ROC) curve analysis were used. Our results demonstrated a positive non-linear correlation between CVAI and VFA (p for non-linear: <0.001). CVAI was significantly associated with increased arterial stiffness (odds ratio (OR): 1.033, 95% confidence interval (CI): 1.020–1.046, p <0.001), after adjusting for other confounders. The restricted cubic spline (RCS) analysis indicated a non-linear correlation between the CVAI and arterial stiffness (p for overall: <0.001, p for non-linear: 0.045). The cut-off value of the CVAI for arterial stiffness was 66.11 (sensitivity, 0.711; specificity, 0.620). CVAI is an independent predictor of arterial stiffness, suggesting its potential as a clinical tool for identifying individuals at risk of arterial stiffness. Not applicable.


  • Open Access

    Hypoxia-inducible factor-1α promotes tubulointerstitial fibrosis via the upregulation of Muc4

    by Zhong-Tang Li, Xin-Hui Hu, Wei-Jie Ni, Zuo-Lin Li, Bi-Kun Huang, Yu Zhang, A-Feng Miao, Jing-Yuan Cao

    Tubulointerstitial fibrosis (TIF) is the common final outcome of almost all progressive chronic kidney diseases (CKDs). Hypoxia-inducible factor-1 (HIF-1) activation plays an essential role in CKD; however, the specific contribution of tubular HIF-1 to renal TIF remains unclear. In the current study, the mechanism underlying HIF-1-mediated TIF was investigated. Intriguingly, we found that specifically knocking out HIF-1α in tubular cells attenuated unilateral ureteral obstruction-induced TIF, as shown by decreased accumulation of the extracellular matrix (ECM). Then, the results of transcriptomic analysis and in vivo and in vitro experiments revealed that expression of Mucin 4 (MUC4) was significantly decreased at the transcriptional and protein levels in tubular HIF-1α-knockout mice. Mechanistically, we demonstrated that HIF-1α directly bound to the Muc4 promoter and enhanced its transcription, as shown by chromatin immunoprecipitation and luciferase reporter assays. Moreover, RNA interference-mediated suppression of MUC4 significantly attenuated transforming growth factor-β induced ECM production by mouse tubular epithelial cells. Furthermore, MUC4 overexpression in the context of HIF-1α knockout was positively correlated with increased ECM protein expression and TIF. Altogether, these results demonstrate that tubular HIF-1α promotes TIF by upregulating Muc4 transcription. Our findings provide novel insights into the molecular mechanism underlying HIF-1-mediated TIF.


  • Open Access

    The Diagnostic Value of Plasma NETs Levels and iCEB in Silent Myocardial Ischemia in Maintenance Hemodialysis Patients

    by Haifei Liu, Junling Han, Weijie Ni, Yuan Lu, Xinhui Hu, Jing Wang, Yan Zhou, Ze Wang, Jingyuan Cao, Hong Liu

    Objective: This study evaluated the diagnostic value of plasma Neutrophil extracellular traps (NETs) levels and the index of cardiac electrophysiological balance (iCEB) in identifying silent myocardial ischemia (SMI) in maintenance hemodialysis (MHD) patients. Methods: This cross-sectional observational study involved patients receiving MHD treatment. Data were collected on coronary angiography performed in our hospital from February 2023 to February 2024. Patients diagnosed with myocardial ischemia via coronary angiography but without obvious symptoms were grouped as the SMI group, while those without SMI were grouped as the control group. Plasma NETs levels were assessed using markers indicative of NETs components including double-stranded DNA (dsDNA), circulating free DNA (cfDNA) and myeloperoxidase, while iCEB (QT/QRS) and electrocardiographic findings were obtained. Additionally, echocardiographic parameters, inflammatory markers, and cardiac biomarkers were analyzed. Receiver operating characteristic (ROC) analysis were employed to evaluate the diagnostic accuracy of plasma NETs levels and iCEB in identifying SMI. Results: A total of 114 patients were included, with 79 participants in the control group and 35 participants in the SMI group. The SMI group exhibited significantly elevated levels of NETs associated components (dsDNA(37.89± 4.55 vs 31.64± 5.32, P< 0.001), cfDNA(11.27± 2.03 vs 8.91± 1.84, P< 0.001), MPO-DNA(23.69± 4.01 vs 17.52± 3.41, P< 0.001)), as well as higher iCEB compared to the control group(56.45± 7.67 vs 45.89± 6.23, P< 0.001). Furthermore, electrocardiography findings, echocardiographic parameters, inflammatory markers, and cardiac biomarkers showed significant differences between the two groups. The ROC analysis demonstrated the potential diagnostic accuracies of NETs levels and iCEB, with an area under the curve (AUC) of 0.908, sensitivity of 0.987, and specificity of 0.829 for identifying SMI. Conclusion: The study highlights the combined diagnostic value of plasma NETs levels and iCEB in identifying SMI in MHD patients, providing valuable insights into potential early detection and risk stratification strategies for this population.


  • Open Access

    Inhibition on neutrophil extracellular traps by oligomeric procyanidins alleviate chemotherapy-induced chronic kidney injury via gut-kidney axis

    by Yaqi Luan, Weiwei He, Kunmao Jiang, Shenghui Qiu, Lan Jin, Xinrui Mao, Ying Huang, Wentao Liu, Jingyuan Cao, Lai Jin, et al.

    Cisplatin is one of the most widely used chemotherapeutic agents for various solid tumors in the clinic, but its use is limited by adverse effects in normal tissues. In particular, cisplatin administration often damages the kidneys. However, little is known about how to alleviate cisplatin-induced chronic kidney disease (CKD) specifically. Here, we found that repeated low-dose cisplatin (RLDC) recruited neutrophils to the proximal tubule, thereby promoting the progression of CKD in the mouse model. Mechanically, cisplatin destroyed the intestinal epithelium, which induced dysregulation of gut flora and intestinal leakage. It triggered Neutrophil extracellular traps (NETs) formation, accumulating in the proximal tubule and promotes chronic inflammation and fibrosis, and promotes chronic hypoxia, leading to poor regeneration that promotes CKD progression. NETs provided a scaffold for tissue factors (TF) adhesion and metalloid-matrix protease 9 (MMP-9) activation, which triggers local ischemia and hypoxia. In addition, NETs promoted inflammasome construction through NOD-like receptor thermal protein domain associated protein 3 (NLRP3) shear and secretion of mature interleukin-18 (IL18), which subsequently released interferon-γ (IFN-γ), contributing to renal interstitial fibrosis. We proposed that oligomeric procyanidins (OPC) ameliorated RLDC-induced CKD through multi-targeting damage induced by NETs. OPC ameliorated microcirculatory disorders and inhibited inflammation by protecting the intestinal mucosa barrier and subsequent bacterial endotoxin translocation. Furthermore, we found that OPC directly blocked LPS & cisplatin-induced NETs formation in vitro. In summary, NETs play a pivotal role in CKD, which OPC alleviates by inhibiting TF/MMP-9 and IL-18-NLRP3 pathways. OPCs protect the kidney by inhibiting NETs production through anti-inflammatory and antioxidant activities and restoring the balance of the intestinal flora


  • Open Access

    The clinical evaluation of the triglyceride-glucose index as a risk factor for coronary artery disease and severity of coronary artery stenosis in patients with chronic kidney disease

    by Dan Liu, Xiaoyang Guan, Ruoxin Chen, Ci Song, Shanhu Qiu, Shengchun Xu, Jingyuan Cao, Hong Liu

    Insulin resistance (IR) plays an important role in the occurrence and development of cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). The triglyceride-glucose (TyG) index is a simple and effective tool to evaluate IR. This study aimed to evaluate the association of the TyG index with coronary artery disease (CAD) and the severity of coronary artery stenosis (CAS) in nondialysis patients with stages 3-5 CKD. Nondialysis patients with stages 3-5 CKD who underwent the first coronary angiography at Zhongda Hospital affiliated with Southeast University from August 2015 to January 2017 were retrospectively analyzed. CAS was measured by coronary angiography, and the CAS score was calculated as the Gensini score. Logistic regression analysis was used to determine the related factors of CAD and severe CAS. A total of 943 patients were enrolled in this cross-sectional study and 720 (76.4%) of these patients were diagnosed with CAD. The TyG index in the CAD group (7.29 ± 0.63) was significantly higher than that in the non-CAD group (7.11 ± 0.61) (p < 0.001). Multivariate logistic regression analysis showed that a higher TyG index was an independent risk factor for CAD in CKD patients after adjusting for related confounding factors (OR = 2.865, 95% CI 1.681-4.885, p < 0.001). Patients in the CAD group were divided into three groups according to the Gensini integral quantile level. Multivariate logistic regression analysis showed that the TyG index was an independent related factor for severe CAS after adjusting for relevant confounding factors (p < 0.001). The TyG index is associated with CAD and the severity of CAS in patients with nondialysis stages 3-5 CKD. A higher TyG index is an independent factor for CAD and severe CAS.